Jeffrey Alan Hawkins Sells 11,311 Shares of Quantum-Si (NASDAQ:QSI) Stock

Quantum-Si Incorporated (NASDAQ:QSI) CEO Jeffrey Alan Hawkins sold 11,311 shares of the business’s stock in a transaction that occurred on Tuesday, June 23rd. The stock was sold at an average price of $0.90, for a total value of $10,179.90. Following the completion of the sale, the chief executive officer directly owned 3,669,802 shares in the company, valued at approximately $3,302,821.80. This represents a 0.31% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Jeffrey Alan Hawkins also recently made the following trade(s):

• On Monday, June 22nd, Jeffrey Alan Hawkins sold 11,310 shares of Quantum-Si stock. The shares were sold at an average price of $0.96, for a total value of $10,857.60.
• On Monday, April 20th, Jeffrey Alan Hawkins sold 83,712 shares of Quantum-Si stock. The shares were sold at an average price of $1.01, for a total value of $84,549.12.

Quantum-Si Trading Down 6.0%

NASDAQ:QSI traded down $0.05 during trading hours on Wednesday, reaching $0.83. 5,042,480 shares of the company traded hands, compared to its average volume of 6,078,957. The business’s 50-day moving average price is $0.99 and its two-hundred day moving average price is $1.04. Quantum-Si Incorporated has a 1 year low of $0.69 and a 1 year high of $3.10. The stock has a market capitalization of $180.13 million, a P/E ratio of -1.62 and a beta of 3.18.

Quantum-Si (NASDAQ:QSI) last released its earnings results on Thursday, May 7th. The company reported ($0.10) EPS for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.02. Quantum-Si had a negative return on equity of 47.35% and a negative net margin of 5,605.88%.The firm had revenue of $0.26 million for the quarter, compared to analysts’ expectations of $0.30 million. As a group, equities analysts anticipate that Quantum-Si Incorporated will post -0.49 EPS for the current year.

Analyst Upgrades and Downgrades

Several analysts recently commented on the stock. Canaccord Genuity Group cut their price objective on shares of Quantum-Si from $1.50 to $1.00 and set a “hold” rating on the stock in a research report on Wednesday, March 4th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Quantum-Si in a report on Friday, March 27th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of “Reduce” and an average target price of $1.00.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Renaissance Technologies LLC purchased a new position in shares of Quantum-Si in the first quarter worth $91,000. Hollencrest Capital Management boosted its position in shares of Quantum-Si by 301.1% during the first quarter. Hollencrest Capital Management now owns 40,111 shares of the company’s stock valued at $31,000 after buying an additional 30,111 shares during the last quarter. Virtu Financial LLC bought a new stake in Quantum-Si in the 4th quarter worth about $262,000. Invesco Ltd. increased its holdings in Quantum-Si by 36.2% in the 4th quarter. Invesco Ltd. now owns 402,821 shares of the company’s stock worth $443,000 after buying an additional 107,093 shares in the last quarter. Finally, XTX Topco Ltd raised its position in Quantum-Si by 206.9% in the 4th quarter. XTX Topco Ltd now owns 461,982 shares of the company’s stock worth $508,000 after buying an additional 311,450 shares during the last quarter. Hedge funds and other institutional investors own 39.90% of the company’s stock.

About Quantum-Si

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.